Galectin Therapeutics (GALT) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.16% |
| Dec 31, 2025 | 19.84% |
| Sep 30, 2025 | 9.23% |
| Jun 30, 2025 | 41.43% |
| Mar 31, 2025 | 36.46% |
| Dec 31, 2024 | -37.08% |
| Sep 30, 2024 | 19.71% |
| Jun 30, 2024 | -17.03% |
| Mar 31, 2024 | -0.91% |
| Dec 31, 2023 | -4.31% |
| Sep 30, 2023 | -1.81% |
| Jun 30, 2023 | 12.95% |
| Mar 31, 2023 | 2.74% |
| Dec 31, 2022 | -30.92% |
| Sep 30, 2022 | 15.94% |
| Jun 30, 2022 | 2.75% |
| Mar 31, 2022 | -33.80% |
| Dec 31, 2021 | 9.93% |
| Sep 30, 2021 | -0.62% |
| Jun 30, 2021 | -29.70% |
| Mar 31, 2021 | 19.34% |
| Dec 31, 2020 | -32.16% |
| Sep 30, 2020 | 2.88% |
| Jun 30, 2020 | -70.26% |
| Mar 31, 2020 | 30.92% |
| Dec 31, 2019 | -81.21% |
| Sep 30, 2019 | 5.20% |
| Jun 30, 2019 | -27.59% |
| Mar 31, 2019 | 20.70% |
| Dec 31, 2018 | -11.38% |
| Sep 30, 2018 | 28.70% |
| Jun 30, 2018 | 10.03% |
| Mar 31, 2018 | -76.06% |
| Dec 31, 2017 | 46.24% |
| Sep 30, 2017 | 2.22% |
| Jun 30, 2017 | 8.73% |
| Mar 31, 2017 | -7.55% |
| Dec 31, 2016 | -1.37% |
| Sep 30, 2016 | 17.97% |
| Jun 30, 2016 | 18.83% |
| Mar 31, 2016 | -45.51% |
| Dec 31, 2015 | 20.61% |
| Sep 30, 2015 | -26.67% |
| Jun 30, 2015 | 3.78% |
| Mar 31, 2015 | -29.62% |
| Dec 31, 2014 | -7.39% |
| Sep 30, 2014 | -3.02% |
| Jun 30, 2014 | 30.33% |
| Mar 31, 2014 | -72.75% |
| Dec 31, 2013 | 20.90% |
| Sep 30, 2013 | -39.18% |
| Jun 30, 2013 | 20.60% |
| Mar 31, 2013 | -34.68% |
| Dec 31, 2012 | 17.75% |
| Sep 30, 2012 | -8.55% |
| Jun 30, 2012 | -36.61% |
| Mar 31, 2012 | 42.08% |
| Dec 31, 2011 | -65.86% |
| Sep 30, 2011 | 32.03% |
| Jun 30, 2011 | -48.58% |
| Mar 31, 2011 | -56.17% |
| Dec 31, 2010 | -6.35% |
| Sep 30, 2010 | 10.22% |